Clinical Trial: Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336940) titled 'Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis' on Sept. 20, 2025.

Brief Summary: The goal of this clinical trial is to learn about the safety and tolerability of ENV-294 in adults with moderate to severe atopic dermatitis. It may also learn about the changes ENV-294 may have on the severity of atopic dermatitis symptoms.

The main questions it will answer are:

* Is ENV-294 safe and well tolerated in adults with moderate to severe atopic dermatitis?

* Is there an impact on the severity of atopic dermatitis symptoms when participants take ENV-294? Researchers will review the atopic dermat...